Trial Condition(s):

Hemophilia A

Drug Use Investigation of Kovaltry in hemophilia A patients

Bayer Identifier:

18706

ClinicalTrials.gov Identifier:

NCT02941783

EudraCT Number:

Not Available

Recruitment Complete

Trial Purpose

The objective in this study is collecting post-marketing information on the safety and efficacy of Kovaltry under the routine clinical practice.

Inclusion Criteria
- Male and female hemophilia A  patients.
 - Patients for whom the decision to treat with Kovaltry was determined prior to enrollment in the study.
Exclusion Criteria
- Patients participating in an investigational program with interventions outside of routine clinical practice.
 - Patients with an additional diagnosis of any bleeding/coagulation disorder other than hemophilia A

Trial Summary

Enrollment Goal
231
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Many Locations

Many Locations, Japan

Status
Recruiting
 

Trial Design